Caplin Point Laboratories has entered into a license and distribution agreement with Cycle Pharmaceuticals, a limited company having its principal offices in Cambridge, UK. Under this agreement, Caplin Point shall be responsible for developing and manufacturing identified liquid injectable products whereas Cycle Pharmaceuticals Limited shall be holding this ANDA and commercialize the same in USA. This is a product specific agreement for United States of America. Currently one product is featuring in the contract.
Caplin Point has already received milestone payment for one product and the product development cum dossier preparation have just commenced.
Cycle Pharmaceuticals is one of the niche global pharmaceutical companies with unique products and sharp focus on key geographies like USA and Europe.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: